Showing results (471-480 of 514) with videos related to

Sort By:
Pageof 52
Pharmaceutics|July 29, 2023
Anticancer Tungstenocenes with a Diverse Set of (O,O-), (O,S-) and (O,N-) Chelates-A Detailed Biological Study Using an Improved Evaluation via 3D Spheroid ModelsKlaudia Cseh, Iker Berasaluce, Valentin Fuchs, et al.
British Journal of Cancer|January 18, 2017
Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistanceB Englinger, M Mair, W Miklos, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2021
Effects of N-terminus modified Hx-amides on DNA binding affinity, sequence specificity, cellular uptake, and gene expressionKonstantinos Kiakos, Vijay Satam, Pravin C Patil, et al.
Pharmaceutics|November 25, 2023
Synthesis and Preclinical Evaluation of Radiolabeled [103Ru]BOLD-100Barbara Happl, Marie Brandt, Theresa Balber, et al.
Pharmaceutics|November 11, 2022
Novel Salinomycin-Based Paramagnetic Complexes-First Evaluation of Their Potential Theranostic PropertiesIrena Pashkunova-Martic, Rositsa Kukeva, Radostina Stoyanova, et al.
Journal of Medicinal Chemistry|October 5, 2010
{(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivoSergey A Abramkin, Ute Jungwirth, Seied M Valiahdi, et al.
Metallomics : Integrated Biometal Science|October 9, 2019
Chemical imaging and assessment of cadmium distribution in the human bodyAlexander E Egger, Gerlinde Grabmann, Can Gollmann-Tepeköylü, et al.
Dalton Transactions (Cambridge, England : 2003)|September 2, 2017
Synthesis and in vivo anticancer evaluation of poly(organo)phosphazene-based metallodrug conjugatesCarmen M Hackl, Beatrix Schoenhacker-Alte, Matthias H M Klose, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 14, 2015
Half-sandwich ruthenium(II) biotin conjugates as biological vectors to cancer cellsMaria V Babak, Damian Plażuk, Samuel M Meier, et al.
Current Cancer Drug Targets|June 11, 2009
Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772)P Heffeter, A Popovic-Bijelic, P Saiko, et al.
Pageof 52